Bleomycins: towards better therapeutics

By Jingyang Chen, J. Stubbe. Nature Reviews. Cancer, 2005

612 citations recorded by the source corpus.

Subfields: Molecular Biology, Organic Chemistry, Plant Science

View Paper: https://www.semanticscholar.org/paper/bc4eae80c1a1569b2f6fb22b01004fcd8b570378

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. J. Haber
2. TA Wynn
3. Anuja S. Mehta

In Organic Chemistry

1. TA Wynn

In Plant Science

1. J. Haber
2. TA Wynn
3. Anuja S. Mehta

Citations in the corpus

• Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium (2018, background): “Finally, another antitumor antibiotic, still widely used in clinical practice today, is bleomycin, discovered in Japan in 1966 and immediately approved for the treatment of various tumors, such as Hodgkin’s and NHL, testicular cancer, and cervical cancer, among others (Umezawa et al., 1966; Chen and”
• Integrating mechanisms of pulmonary fibrosis (2011, background): “Lung fibrosis can also develop after viral infections and after exposure to radiotherapy, chemotherapeutic drugs, and aerosolized environmental toxins (Denham and Hauer-Jensen, 2002; Kelly et al., 2002; Fubini and Hubbard, 2003; Chen and Stubbe, 2005).”
• Sources of DNA double-strand breaks and models of recombinational DNA repair. (2014, background): “Chemotherapeutic drugs include DNA-alkylating agents such as methyl methanosulfonate and temozolomide, cross-linking agents such as mitomycin C and cisplatin, and radiomimetic compounds such as bleomycin or phleomycin (Chen and Stubbe 2005; Wyrobek et al. 2005).”